AVE avecho biotechnology limited

market captiulation, page-7

  1. 10,009 Posts.
    Jevalent, I am not happy...But do see a bright future...This is a turnaround situation...

    The. Main objective of the CEO and Board is to grow shareholder wealth......

    That will happen next year...The deals are all happening post PH2 trials... This OXYMORPHONE patch will be very valuable...

    But until then disappointment from long term shareholders will weigh heavily.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
0.001(11.1%)
Mkt cap ! $14.28M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $200 40K

Buyers (Bids)

No. Vol. Price($)
29 23540599 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 27692940 23
View Market Depth
Last trade - 09.59am 28/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.